The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, ...

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

Novavax (NVAX) closed at $6.36 in the latest trading session, marking a -2.15% move from the prior day. This move lagged the ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.